PLAT and intracerebral hemorrhage: Currently, tNK/tPA is administered within a 3–4.5 h window following symptom onset; however, there is still debate regarding the efficacy of administering tNK/tPA in an extended window, as administration further from symptom onset has been associated with a greater risk of developing symptomatic intracerebral hemorrhage (sICH) and mortality [4].